Lans Taylor, Co-director of the HSLBC and director of the Drug-discovery Institute along with Alex Soto-Gutierrez, co-director of the HSLBC, and Lawrence Vernetti, as well as PLRC members-elect Mark Miedel and Mark Schurdak were awarded an MPI Center grant from National Center for Advancing Translational Sciences. CONGRATULATIONS!
The Title of the Grant is: “Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection“
The University of Pittsburgh TraCe MPS Center’s (Pitt-TraCe) qualified, patient-derived, structured, biomimetic liver Microphysiology Systems (MPS) platform will deliver qualified DDTs that will dramatically improve the efficiency and accuracy in liver safety and efficacy for drug development decisions, especially for complex heterogeneous diseases in precision medicine. These commercially available, qualified DDTs will benefit the drug development process for the pharmaceutical industry and FDA regulatory oversight. In addition, the Automated Biomimetic Analytic MPS (ABAMPS) platform employing commercially available materials from can be harnessed to qualify new organ structured, biomimetic MPS in the future.